TNBCs represent 10–15% of all subtypes of breast cancers and are so named because of the absence of estrogen receptor (ER), progesterone receptor (PR) and no overexpression of human epidermal growth factor receptor 2 (HER2) [1]. Here, PGR is linked to breast carcinoma.